nalidixic acid has been researched along with ciprofloxacin in 447 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 83 (18.57) | 18.7374 |
| 1990's | 63 (14.09) | 18.2507 |
| 2000's | 174 (38.93) | 29.6817 |
| 2010's | 110 (24.61) | 24.3611 |
| 2020's | 17 (3.80) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Blyn, LB; Jefferson, EA; Miyaji, A; Osgood, SA; Risen, LM; Swayze, EE | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Bachand, B; Barnes, MH; Bethell, R; Brown, NC; Butler, MM; Cadilhac, C; Charron, S; Comstock, J; Dix, EJ; Foster, KA; Holm, KA; LaMarr, WA; Lamothe, S; Long, ZY; Manikowski, A; Motorina, I; Storer, R; Tarantino, PM; Wright, GE; Xu, WC; Zhi, C | 1 |
| Drlica, K; Hussain, S; Malik, M | 1 |
| Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
| Choi, TY; Pai, H; Seo, MR | 1 |
| Barnes, MH; Bowlin, TL; Brown, NC; Butler, MM; Foster, KA; Kustigian, LM; Lamarr, WA; Lyden, PT; Skow, DJ; Wright, GE; Zhi, C | 1 |
| Catalan, A; de la Campa, AG; Dominguez, L; Escudero, JA; Gonzalez-Zorn, B; Lopez, G; Moreno, MA; Rivero, E; San Millan, A | 1 |
| Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Campos, J; García-Cobos, S; Pérez-Vázquez, M; Román, F | 1 |
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
| Cattoir, V; Mazel, D; Nordmann, P; Poirel, L; Soussy, CJ | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 2 |
| Bartoloni, A; Di Maggio, T; Fiorelli, C; Gamboa, H; Gotuzzo, E; Kronvall, G; Mantella, A; Pallecchi, L; Paradisi, F; Rossolini, GM | 1 |
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Brazas, MD; Breidenstein, EB; Hancock, RE; Overhage, J | 1 |
| Acosta, CJ; Agtini, M; Albert, MJ; Anh, DD; Arjyal, A; Basnyat, B; Bhattacharya, SK; Bhutta, ZA; Campbell, JI; Canh, DG; Chau, TT; Chinh, NT; Clemens, JD; Diep, TS; Dolecek, C; Dong, B; Dougan, G; Dutta, S; Farrar, J; Galindo, CM; Hien, TT; Honghui, Y; La, TT; Naheed, A; Newton, PN; Nga, TT; Ochiai, RL; Page, AL; Parry, CM; Phetsouvanh, R; Phuong, LT; Rang, NN; Schultsz, C; Tuan, PQ; Van Be Bay, P; Van Minh Hoang, N; Van Vinh Chau, N; Vinh, H; von Seidlein, L; Wain, J | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Collins, MT; Shin, SJ | 1 |
| de Jong, A; Friederichs, S; Kehrenberg, C; Schwarz, S | 1 |
| Jones, GL; Stickler, DJ | 1 |
| Bertolini, T; Chow, C; Froelich, JM; Hermann, T; Murphy, DE; Sun, Z; Wall, D; Webber, SE; Zhou, Y | 1 |
| Abouzeed, YM; Baucheron, S; Cloeckaert, A | 1 |
| Arakawa, Y; Chen, L; Chen, ZL; Deng, YT; Gao, JH; Liu, JH; Zeng, ZL | 1 |
| Chen, X; Fu, Y; Gu, J; Guo, L; Liu, X; Ma, J; Xu, J; Xu, Y; Zhang, F; Zhang, W; Zhao, Y | 1 |
| Alba, V; Alcalde, E; Blasco, MD; Esteve, C; Marti, S; Sánchez-Céspedes, J; Vila, J | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Carmeli, Y; Chmelnitsky, I; Navon-Venezia, S; Strahilevitz, J | 1 |
| Cattoir, V; Espinal, P; Nordmann, P; Poirel, L; Silva-Sanchez, J | 1 |
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 2 |
| Bailey, AM; Paulsen, IT; Piddock, LJ | 1 |
| Bremont, S; Charavay, F; Courvalin, P; Goarant, C; Le Hello, S; O'Connor, O; Page, S; Vernel-Pauillac, F | 1 |
| Cho, DT; Kang, HY; Kim, J; Lee, JC; Lee, YC; Oh, JY; Seol, SY; Tamang, MD | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Abad, R; Enríquez, R; Salcedo, C; Vázquez, JA | 1 |
| Aarestrup, FM; Cavaco, LM; Hasman, H; Xia, S | 1 |
| Brun, R; Ma, X; Zhou, W | 1 |
| Manian, RD; Raghunathan, M; Raghunathan, R; Ramesh, E; Sainath, S | 1 |
| Fanning, S; McCusker, M; O'Regan, E; Pagès, JM; Piddock, L; Quinn, T | 1 |
| Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
| Bartalesi, F; Bartoloni, A; Gamboa, H; Gotuzzo, E; Mantella, A; Pallecchi, L; Riccobono, E; Rossolini, GM; Sennati, S | 1 |
| Accogli, M; Caprioli, A; Carattoli, A; Cerquetti, M; Fortini, D; García-Fernández, A; Giufrè, M; Graziani, C; Luzzi, I | 1 |
| Dionisi, AM; Lucarelli, C; Luzzi, I; Owczarek, S; Villa, L | 1 |
| Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J | 1 |
| Caddick, JM; Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lilly, AJ; Piddock, LJ; Siitonen, A; Webber, MA | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Barrow, K; Kwon, DH | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| Fanning, S; Fedorka-Cray, PJ; Frye, JG; McClelland, M; O'Regan, E; Pagès, JM; Porwollik, S; Quinn, T | 1 |
| Ahmed, S; Calderwood, SB; Faruque, AS; Hooper, DC; Jacoby, GA; Khan, WA; Kim, HB; LaRocque, RC; Park, CH; Qadri, F; Salam, MA; Wang, M | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Bartalesi, F; Bartoloni, A; Gotuzzo, E; Mantella, A; Pallecchi, L; Riccobono, E; Rossolini, GM; Sennati, S; Trigoso, C | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Bisgaard, M; Bojesen, AM; Bortolaia, V; Guardabassi, L; Trevisani, M; Venturi, L | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Ahn, JH; Bae, IK; Lee, JE; Lee, JJ; Lee, SH; Park, I; Park, KS; Sun, HI; Woo, GJ | 1 |
| Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Siitonen, A | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Bialek, S; Chevalier, J; Davin, A; Lavigne, JP; Leflon-Guibout, V; Marcon, E; Moreau, R; Nicolas-Chanoine, MH; Pagès, JM | 1 |
| Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Girgis, AS; Hall, CD; Katritzky, AR; Liaqat, S; Panda, SS; Samir, A | 1 |
| Peraman, R; Reddy, YP; Varma, RV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Bartůněk, P; Benada, O; Bogdanová, K; Ehn, M; Fišer, R; Kolář, M; Krásný, L; Křížek, T; Panova, N; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedlák, D; Seydlová, G; Šimák, O; Sudzinová, P; Večeřová, R; Vítovská, D; Zborníková, E | 1 |
| Ba, Y; Wang, S; Xu, Z; Zhang, J | 1 |
| Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
| Chyrek-Borowska, S; Michalska, I; Siergiejko, Z; Szymański, W | 1 |
| Gootz, TD; Martin, BA | 1 |
| Masecar, BL; Robillard, NJ | 1 |
| Bailey, DL; Epling, GA; Kiely, JS; Robertson, DG; Song, B | 1 |
| Hall, MC; Piddock, LJ; Walters, RN | 1 |
| Howard, BM; Lewin, CS; Smith, JT | 1 |
| Heisig, P; Wiedemann, B | 1 |
| Corkill, JE; Lind, M; Percival, A | 1 |
| Adler-Mosca, H; Altwegg, M; Burnens, A; Lüthy-Hottenstein, J; Martinetti Lucchini, G | 1 |
| Cullmann, W; Dechène, M; Leying, H | 1 |
| Phillips, AC; Towner, KJ | 1 |
| Ferguson, J; Johnson, BE | 1 |
| Blakemore, P; Drabu, YJ; Lewin, CS; Smith, JT | 1 |
| Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Lewin, CS; Smith, JT | 2 |
| Deforges, L; Duval, J; Leclercq, R; Soussy, CJ | 1 |
| Adair, CG; Casabar, E; Kasik, JE; Lettieri, J; Prince, RA; Wexler, DB | 1 |
| Focht, J; Klietmann, W; Nösner, K | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Rehavi, M; Rubinstein, E; Segev, S | 1 |
| Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Dent, J; McNulty, CA; Wise, R | 1 |
| Guimaraes, MA; Noone, P | 1 |
| Geitz, JN; Lerk, CF; Tarko-Smit, NJ; Van Saene, HK; Van Saene, JJ | 1 |
| Lerk, CF; van Saene, HK; van Saene, JJ | 1 |
| Newsom, SW | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Avesani, V; Delmee, M | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Barba, D; Esposito, S; Galante, D; Pennucci, C | 2 |
| Forsgren, A; Persson, KM | 1 |
| Baltch, AL; Bassey, CM; Smith, RP | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Andrews, JM; Diver, JM; Piddock, LJ; Wise, R | 1 |
| Grimm, H | 1 |
| Høiby, N | 1 |
| Hooper, DC; Ng, EY; Swartz, MN; Wolfson, JS | 1 |
| Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
| Gahrn-Hansen, B; Søgaard, P | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Kubesch, P; Tümmler, B; Wehsling, M | 1 |
| Andrews, JM; Ashby, JP; Wise, R | 1 |
| Kresken, M; Wiedemann, B | 1 |
| Dubois, J; Fontaine, V | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Traub, WH | 2 |
| Forsgren, A | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| Gordin, FM; Hackbarth, CJ; Sande, MA; Scott, KG | 1 |
| Bailey, J; Heppleston, C; Richmond, S | 1 |
| Oliva, B; Ravagnan, G; Renzini, G; Selan, L | 1 |
| Dabernat, H; Delmas, C; Lareng, MB | 1 |
| Bergogne-Berezin, E; Joly-Guillou, ML | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Petrou, MA; Rogers, TR | 1 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Walker, RC; Wright, AJ | 1 |
| King, A; Phillips, I; Shannon, K; Slegg, J | 1 |
| King, A; Phillips, I | 1 |
| Wolff, M | 1 |
| Smith, JT | 3 |
| Elliott, TS; Greenwood, D; Shelton, A | 1 |
| Gau, W; Petersen, U; Ploschke, HJ; Zeiler, HJ | 1 |
| Coll, R; Esteve, M; Moros, M; Parés, J; Xicota, MA | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Greenwood, D; Laverick, A | 1 |
| Bannatyne, RM; Cheung, R; Toma, S | 1 |
| Andrews, JM; Edwards, LJ; Wise, R | 1 |
| Bauernfeind, A; Petermüller, C | 1 |
| Muytjens, HL; van der Ros-van de Repe, J; van Veldhuizen, G | 1 |
| Fass, RJ | 1 |
| Heessen, FW; Muytjens, HL | 1 |
| Chin, NX; Neu, HC | 1 |
| King, A; Phillips, I; Shannon, K | 1 |
| Bywater, MJ; Holt, HA; Reeves, DS; White, LO | 1 |
| Ayers, LW; Barry, AL; Gerlach, EH; Jones, RN; Sommers, HM; Thornsberry, C | 1 |
| Barry, AL; Jones, RN | 1 |
| DeYoung, DR; Gay, JD; Roberts, GD | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Grohe, K; Zeiler, HJ | 1 |
| Gabriel, FG; Mumtaz, G; Oriel, JD; Ridgway, GL | 1 |
| Diez-Enciso, M; Gutierrez-Altes, A; Mas-Jimenez, G; Velasco-Cerrudo, A | 1 |
| Machka, K | 1 |
| Balg, H; Machka, K | 1 |
| Peeters, M; Piot, P; Van Dyck, E | 1 |
| Dørflinger, T; Frimodt-Møller, PC; Madsen, PO | 1 |
| Baxter, S; Cowlishaw, A; Eley, A; Greenwood, D; Slater, GJ | 1 |
| Meier-Ewert, H; Millott, G; Weil, G | 1 |
| Autuly, F; Avril, JL; Couete, I; Plessis, P; Travert, MF | 1 |
| Gensberg, K; Jin, YF; Piddock, LJ | 1 |
| Howard, BM; Pinney, RJ; Smith, JT | 2 |
| Bamber, AI; Corkill, JE; McDonald, P; Percival, A | 1 |
| Fernandez-Baca, V; Reina, J; Ros, MJ | 1 |
| Kasatkina, IV; Lozovoĭ, NV; Pasiukov, VV; Shcherbaniuk, AI | 1 |
| Griggs, DJ; Hall, MC; Jin, YF; Piddock, LJ | 1 |
| Domarle, O; Hayem, G; Pocidalo, JJ; Thuong-Guyot, M | 1 |
| Kasatkina, IV; Makarovskaia, LN; Padeĭskaia, EN; Sherbaniuk, AI | 1 |
| Buchrieser, C; Kaspar, CW | 1 |
| Mamet, R; Schoenfeld, N | 1 |
| Ichikawa, N; Iwamoto, K; Naora, K | 1 |
| Akard, L; Allen, SD; Black, JR; Cromer, M; Jansen, J; Wheat, LJ | 1 |
| Phillips, I; Power, EG | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Dávila, I; De La Hoz, B; Diez, ML; Fraj, J; Lazaro, M; Quirce, S | 1 |
| Darkin-Rattray, S; Lawrence, JW; Neims, AH; Rowe, TC; Xie, F | 1 |
| Amyes, SG; Brown, JC; Jesudason, MV; Shanahan, PM; Thomson, CJ | 1 |
| Rosen, JE; Schluter, G; Williams, GM | 1 |
| Gutmann, L; Moreau, NJ; Nguyen Van, JC; Shlaes, D; Truong, QC | 1 |
| Dai, J; Meatherall, R | 1 |
| Ban, Y; Deguchi, T; Fukuoka, A; Ishihara, S; Kanematsu, E; Kawada, Y; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
| Klecak, G; Urbach, F; Urwyler, H | 1 |
| Forbes, PD; Mäkinen, M; Stenbäck, F | 1 |
| Churilla, AM; el-Etr, SH; Gabriel, ME; Ismail, TF; Oyofo, BA; Peruski, LF; Petruccelli, BP; Wasfy, MO | 1 |
| Borrego, JJ; Castro, D; Goñi, P; Ruiz, J; Santamaria, JA; Vila, J | 1 |
| Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
| Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
| Farinelli, S; Iegri, F; Iona, E; Mascellino, MT | 1 |
| Jacoby, GA; Martínez-Martínez, L; Pascual, A | 1 |
| Chen, SN; Lee, KK; Liu, PC | 1 |
| Atanassova, V; Ring, C | 1 |
| Aardema, MJ; Gibson, DP; Ma, X; Murphy, VA; Switzer, AG | 1 |
| Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
| Gaudreau, C; Gilbert, H | 2 |
| Sanders, CC; Thomson, KS | 1 |
| Castillo, FJ; Clavel, A; López, L; Rubio, MC; Seral, C | 1 |
| Bender, JB; Besser, JM; Hedberg, CW; Johnson, BP; Leano, FT; Moore, KA; Osterholm, MT; Smith, KE; Wicklund, JH | 1 |
| Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
| Maskell, JP; Sefton, AM; Williams, JD | 1 |
| Dorlencourt, F; Legros, D; Paquet, C; Saoult, E | 1 |
| Hakanen, A; Huovinen, P; Jalava, J; Kotilainen, P; Siitonen, A | 1 |
| de Anta, MT; Navia, MM; Ribera, A; Ruiz, J; Vila, J | 1 |
| Frost, JA; Thwaites, RT | 1 |
| Hernández, C; Rodríguez, JC; Royo, G; Ruiz, M; Sirvent, E | 1 |
| Drlica, K; Fournier, B; Hooper, DC; Lu, T; Zhao, X | 1 |
| Berlanga, M; Viñas, M | 1 |
| Besser, J; Helsel, L; Li, Y; Swaminathan, B; Zirnstein, G | 1 |
| Demple, B; Koutsolioutsou, A; Levy, SB; Martins, EA; White, DG | 1 |
| Alós, JI; Aracil, B; Gómez-Garcés, JL; Oteo, J | 1 |
| Hirose, K; Sagara, H; Tamura, K; Watanabe, H | 1 |
| Chaslus-Dancla, E; Cloeckaert, A; Dho-Moulin, M; Flaujac, G; Giraud, E; Leroy-Sétrin, S | 1 |
| Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
| Cid, D; de la Fuente, R; Díez, R; Martínez, S; Orden, JA; Ruiz-Santa-Quiteria, JA | 1 |
| Cambau, E; Fiévet, MH; Grenet, K; Jarlier, V; Péan, Y; Robert, J; Trystram, D | 1 |
| Bachoual, R; Lascols, C; Mory, F; Ouabdesselam, S; Soussy, CJ; Tankovic, J | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Janicka, G; Kłyszejko, C; Sekowska, A; Szymankiewicz, M; Wojda, M; Wróblewski, M | 1 |
| Jiminez de Anta, MT; Ribera, A; Ruiz, J; Vila, J | 1 |
| Cassar, CA; Clifton-Hadley, FA; Clouting, C; Davies, RH; Liebana, E; Randall, LP; Ridley, AM; Threlfall, EJ; Walker, RA | 1 |
| Gómez, J; Marco, F; Mensa, J; Navia, MM; Ribera, A; Ruiz, J; Sierra, JM; Vila, J | 1 |
| Bhat, GK; Ciraj, AM; Seema, DS; Shivananda, PG | 1 |
| Everett, MJ; Jin, YF; Piddock, LJ; Webber, MA | 1 |
| Das, B; Kapil, A | 1 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Barranco, M; Horcajada, JP; Mensa, J; Moreno, A; Ruiz, J; Simon, K; Velasco, M; Vila, J | 1 |
| Eaves, DJ; Liebana, E; Piddock, LJ; Woodward, MJ | 1 |
| Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q | 1 |
| Bell, J; Kaneene, JB; Linz, JE; Padungtod, P; Wilson, DL | 1 |
| Balaji, V; Jesudason, MV; Thomson, CJ | 1 |
| Bartelt, E; Genschow, E; Hahn, H; Luber, P; Wagner, J | 1 |
| Adley, CC; Gorman, R | 1 |
| Andrews, JM; Brenwald, NP; Jevons, G; Wise, R | 1 |
| Asna, SM; Haq, JA; Rahman, MM | 1 |
| Aguilar, L; Garcia-Mendez, E; Jiménez De Anta, MT; Marco, F; Mensa, J; Ruiz, J; Sierra, JM; Vila, J | 1 |
| Johnson, MM; Piddock, LJ; Webber, MA | 1 |
| Chatterji, M; Nagaraja, V; Sengupta, S | 1 |
| Dornbusch, K; Fendukly, F; Hanson, HS; Karlsson, I; Kronvall, G | 1 |
| Mendoza, MC; Ruíz, J; Soto, SM; Vila, J | 1 |
| Guerra, B; Helmuth, R; Malorny, B; Schroeter, A | 1 |
| Avlami, A; Chaniotaki, S; Giakouppi, P; Kozanitou, M; Panagiotakos, D; Petrikkos, G; Tzouvelekis, LS; Vatopoulos, AC | 1 |
| Delsol, AA; Roe, JM; Woodward, MJ | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Aracil, B; Campos, J; Cantón, R; Pérez-Vázquez, M; Román, F | 1 |
| Albayrak, F; Aysev, AD; Cokca, F; Erdem, B | 1 |
| Capilla, S; Castillo, J; Gómez-Lus, R; Goñi, P; Jiménez de Anta, MT; Rubio, MC; Ruiz, J; Vila, J | 1 |
| Cebula, TA; Levy, DD; Sharma, B | 1 |
| Al-Mulhim, K; Panhotra, BR; Saxena, AK | 1 |
| Murakawa, GJ; Sable, D | 1 |
| Escribano, I; Rodríguez, JC; Royo, G | 1 |
| Desjardins, M; Guibord, C; Jessamine, P; McCarthy, AE; Ramotar, K; Slinger, R; Toye, B | 1 |
| Cilla, G; Gomáriz, M; Marimón, JM; Pérez-Trallero, E; Zigorraga, C | 1 |
| Al-Ghamdi, AM; Panhotra, BR; Saxena, AK | 1 |
| Hänninen, ML; Laatu, M; Rautelin, H | 1 |
| Carranza, C; Corso, A; Faccone, D; Galas, M; Miranda, M; Regueira, M; Rodriguez, M; Vazquez, JA; Vencina, C | 1 |
| Cebrián, L; Escribano, I; Rodríguez, JC; Royo, G | 1 |
| Haq, JA; Morshed, MA; Rahman, MA; Rahman, MM | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Kabra, SK; Kadhiravan, T; Kapil, A; Misra, A; Renuka, K; Wig, N | 1 |
| Brown, DJ; Coia, JE; Mather, H; Murray, A | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| Ison, C; Livermore, DM; Ragunathan, PL | 1 |
| Asonganyi, ED; Njunda, AL; Nkemngu, NJ | 1 |
| Dargatz, DA; Englen, MD; Fedorka-Cray, PJ; Ladely, SR | 1 |
| Drews, SJ; Green, K; Low, DE; Mazzulli, T; McGeer, AJ; Pong-Porter, S; Poutanen, SM; Rzayev, Y; Sarabia, A; Willey, B | 1 |
| Biswal, M; Sharma, M; Taneja, N; Tarai, B | 1 |
| Aggarwal, P; Gaind, R; Kalaivani, M; Mehta, R; Paul, P; Walia, M | 1 |
| Choi, MS; Choi, SH; Choo, EJ; Jeong, JY; Kim, MN; Kim, NJ; Kim, YS; Kwak, YG; Lee, BK; Lee, JE; Lee, NY; Park, SJ; Ryu, J; Woo, JH | 1 |
| Colodner, R; Johnson, JR; Johnston, B; Kuskowski, MA; Raz, R | 1 |
| Arjyal, A; Pandit, A | 1 |
| Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lindgren, M; Siitonen, A | 1 |
| Johnson, JR | 1 |
| Corcoran, D; Cotter, L; Fanning, S; O'Halloran, F; Quinn, T | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Cardinale, E; Mead, G; Perrier Gros-Claude, JD; Rivoal, K; Rose, V; Salvat, G; Tall, F | 1 |
| Ball, D; Choudhury, M; Garelick, H; Jacobs, J; Jones, H; Soonthornchaikul, N | 1 |
| Jjemba, PK; Kinkle, BK; Shann, JR | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Englen, MD; Fedorka-Cray, PJ; Jesse, TW; Pittenger-Alley, LG | 1 |
| Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M | 1 |
| Ercis, S; Erdem, B; Gür, D; Hasçelik, G | 1 |
| Bahsoun, I; Boye, CS; Breurec, S; Cardinale, E; Garin, B; Kinana, AD; Perrier-Gros-Claude, JD; Sire, JM; Tall, F | 1 |
| de Jong, A; Friederichs, S; Kehrenberg, C; Michael, GB; Schwarz, S | 1 |
| Nair, S; Turner, AK; Wain, J | 1 |
| Garg, RK; Marak, RS; Ray, P; Sharma, J | 1 |
| Cebrian, L; Escribano, I; Pertegás, V; Rodríguez, JC; Royo, G | 1 |
| Charlett, A; Day, M; de Pinna, E; Goodyear, KL; Threlfall, EJ | 1 |
| Angulo, FJ; Barrett, TJ; Chiller, TM; Gay, K; Medalla, F; Stevenson, JE | 1 |
| Kownhar, H; Rajan, R; Rao, UA; Shankar, EM | 1 |
| Cebrián, L; Escribano, I; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
| Albaksami, O; Dimitrov, T; Kilani, AA; Shehab, EMR; Udo, EE | 1 |
| Bahsoun, I; Breurec, S; Cardinale, E; Garin, B; Kinana, AD; Perrier-Gros-Claude, JD; Saad-Bouh Boye, C; Sire, JM; Tall, F | 1 |
| Alonso, JM; Merino, LA; Ruiz, J; Vila, J | 1 |
| Bangtrakulnonth, A; Chatsuwan, T; Chongthaleong, A; Kulwichit, W; Pulsrikarn, C; Unhasuta, C | 1 |
| Dargatz, DA; Englen, MD; Fedorka-Cray, PJ; Hill, AE; Ladely, SR | 1 |
| Bhattacharya, SK; Bhattarai, NR; Deb, M; Kanungo, R; Khanal, B; Sharma, SK | 1 |
| Manfreda, G; Pasquali, F; Rossi, M; Zanoni, R | 1 |
| Aggarwal, P; Bifani, PJ; Capoor, MR; Dehem, M; Mathys, V; Nair, D | 1 |
| Al-Ghamdi, AG; Al-Khuwaitir, TS; Al-Zuhair, AA; Khan, A | 1 |
| Aubert, G; Carricajo, A; Fonsale, N; Vautrin, AC | 1 |
| Lucchi, A; Manfreda, G; Pasquali, F | 1 |
| Khan, MA; Mirza, SH | 1 |
| Aarestrup, FM; Cavaco, LM; Frimodt-Møller, N; Guardabassi, L; Hasman, H; Nielsen, L | 1 |
| Dalla Costa, LM; Gales, AC; Ito, CA; Munerato, P; Tognim, MC | 1 |
| Bingen, E | 1 |
| Jung, J; Lee, K; Lee, M; Lee, Y; Lim, J; Park, Y | 1 |
| Hakanen, AJ; Huovinen, P; Hurme, S; Kotilainen, P; Lindgren, MM; Lukinmaa, S; Piddock, LJ; Siitonen, A; Webber, MA | 1 |
| Hong, SG; Jongwook, L; Kim, SI; Kim, SY; Kwak, HS; Park, YJ; Uh, Y; Yu, JK | 1 |
| Dhanapal, LP; Morse, AN | 1 |
| Kapil, A; Kapoor, R; Rajeswari, MR; Subbarao, N; Vashist, J; Yennamalli, R | 1 |
| Govender, N; Keddy, KH; Smith, AM | 1 |
| Garelick, H; Soonthornchaikul, N | 1 |
| Hayashi, A; Inoue, K; Kamakura, K; Kashiwagi, E; Kawahara, R; Seto, K; Taguchi, M; Yamagata, N | 1 |
| Kumar, Y; Mani, KR; Sharma, A | 1 |
| du Merle, L; Fàbrega, A; Jiménez de Anta, MT; Le Bouguénec, C; Vila, J | 1 |
| Alvarado, D; del Valle, LJ; Flores, L; García-de-la-Guarda, R; Ibañez, ZB; Quispe, RL; Ramírez, P; Ruiz, J; Vargas, M | 1 |
| Aristilde, L; Melis, A; Sposito, G | 1 |
| Jang, SJ; Kim, DM; Kim, SH; Lee, BK; Neupane, GP | 1 |
| Białucha, A; Gospodarek, E; Kozuszko, S | 1 |
| Alessiani, A; Amicosante, G; Di Giannatale, E; Forcella, C; Perilli, M; Zilli, K | 1 |
| Kim, DM; Kim, SH; Lee, BK; Neupane, GP | 1 |
| Gaborieau, V; Marchou, B; Weill, FX | 1 |
| Majtan, J; Majtan, V; Majtanova, L | 1 |
| Agtini, MD; Arjyal, A; Baker, S; Basnyat, B; Bhattacharya, SK; Bhutta, ZA; Campbell, JI; Canh, DG; Chinh, NT; Clemens, J; Dolecek, C; Dong, B; Dongol, S; Duy, PT; Farrar, JJ; Karkey, A; Naheed, A; Ochiai, L; Parry, CM; Thieu Nga, TV; Thuy, CT; Tinh Hien, T; Van Minh Hoang, N; Vinh, H; Wain, J | 1 |
| Fàbrega, A; Lunn, AD; Sánchez-Céspedes, J; Vila, J | 1 |
| De Cesare, A; Lucchi, A; Manfreda, G; Pasquali, F; Piva, S; Rossi, M; Zanoni, RG | 1 |
| Al-Mashhadani, M; Beeching, NJ; Hewson, R; Keenan, A; Parry, CM; Vivancos, R; Wain, J | 1 |
| Goessens, WH; Hassing, RJ; Menezes, GA; Petit, PL; van Genderen, PJ; van Pelt, W | 1 |
| Kreienbrock, L; Ruddat, I; Schwarz, S; Tietze, E; Ziehm, D | 1 |
| Ryzhko, IV; Trishina, AV; Verkina, LM | 1 |
| Christiansen, N; Frimodt-Møller, N; Hansen, LH; Jakobsen, L; Nielsen, L; Stegger, M | 1 |
| Fanning, S; Karczmarczyk, M; Leonard, N; Martins, M; Quinn, T | 1 |
| Almofti, YA; Dai, M; Hao, H; Huang, L; Liu, Z; Sun, Y; Wang, Y; Yuan, Z | 1 |
| Arlet, G; Emond, JP; Smati, M; Tankovic, J | 1 |
| Cao, Y; Gu, B; Liu, G; Pan, S; Peng, Z; Qian, H; Tong, M; Wei, Y; Yu, R; Zhao, L; Zhuang, L | 1 |
| Bello-Toledo, H; Domínguez-Yévenes, M; Elgorriaga-Islas, E; García-Cañete, P; González-Rocha, G; Guggiana-Nilo, P; Labarca-Labarca, J; Mella-Montecinos, S | 1 |
| Fakhr, MK; Noormohamed, A | 1 |
| Acharya, D; Korbsrisate, S; Madhup, SK; Trakulsomboon, S | 1 |
| Igbinosa, IH; Okoh, AI | 1 |
| Cui, S; Cui, X; Gu, Y; Hou, X; Lin, L; Ren, X; Xu, X | 1 |
| Ikonen, I; Lyhs, U; Pelkonen, S; Perko-Mäkelä, P; Pohjanvirta, T; Raninen, K | 1 |
| Chae, MH; Gurung, M; Jang, GC; Jung, SC; Kim, SR; Lim, SK; Nam, HM; Tamang, MD | 1 |
| Bareja, E; Chróst, A; Gierczyński, R; Januszkiewicz, A; Olak, M; Piekarska, K; Rzeczkowska, M; Zacharczuk, K | 1 |
| Adachi, F; Kawahara, R; Takakura, K; Yamamoto, A | 1 |
| Cho, JK; Kim, JH; Kim, KS | 1 |
| Carson, L; Irwin, NJ; McCoy, CP | 1 |
| Choudhary, A; Ghafur, KA; Gopalakrishnan, R; Nambi, PS; Ramasubramanian, V; Thirunarayan, MA | 1 |
| Kania, I; Osek, J; Wieczorek, K | 1 |
| Aedo, S; Tse-Dinh, YC | 1 |
| Batra, P; Dutta, R; Dwivedi, M; Saxena, S | 1 |
| Del Valle, LJ; Gomes, C; Mosquito, S; Ochoa, TJ; Pons, MJ; Ruiz, J | 1 |
| Ahmed, D; Akter, M; Azmi, IJ; Faruque, AS; Faruque, SM; Hasan, TN; Hossain, MA; Latif, HA; Shahnaij, M; Talukder, KA; Ud-Din, AI; Wahid, SU | 1 |
| Fruth, A; Helmuth, R; Junker, E; Malorny, B; Tietze, E; Toboldt, A | 1 |
| Hoszowski, A; Wasyl, D; Zając, M | 1 |
| Ambali, A; Ameh, JA; Coker, AO; Fashae, K; Hendriksen, RS; Ogunsola, FT; Raufu, IA | 1 |
| Ballesté-Delpierre, C; Fàbrega, A; Fernández-Orth, D; Jiménez de Anta, MT; Soto, SM; Vila, J | 1 |
| Kirkpatrick, CL; Viollier, PH | 1 |
| Fiebig, A | 1 |
| Allum, AG; Grude, N; Henriksen, IH; Jenkins, A; Kristiansen, BE; Strand, L | 1 |
| Blanco, MM; Cutuli, MT; Díaz de Alba, P; Gibello, A; Machuca, J; Rodríguez-Martínez, JM | 1 |
| Firoozeh, F; Soleimani-Asl, Y; Zibaei, M | 1 |
| Chen, PC; Chiou, CS; Kuo, JC; Lauderdale, TL; Liang, SY; Liu, YY; Phung, DC; Wang, PJ; Watanabe, H | 1 |
| Ardanuy, C; Calatayud, L; de la Campa, AG; Garmendia, J; Liñares, J; Marti, S; Puig, C; Tirado-Vélez, JM; Tubau, F | 1 |
| Khan, S; Kweon, O; Nawaz, M; Nawaz, S; Steele, R; Sung, K | 1 |
| Alonso-Sanz, M; González-Abad, MJ | 1 |
| Botello, E; García-Cañas, A; González-Soltero, R; Mendoza-Chamizo, B; Mohedano, RB | 1 |
| Grillo-Puertas, M; Martínez-Zamora, MG; Rapisarda, VA; Rintoul, MR; Soto, SM | 1 |
| Ahmed, S; Bennish, ML; Khan, WA; Saha, D; Salam, MA | 1 |
| Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M | 1 |
| Chai, LC; Ngoi, ST; Teh, CS; Thong, KL | 1 |
| do Nascimento, VP; Gomes, MJ; Moraes, HL; Morgan, RB; Perdoncini, G; Salle, CT; Sierra-Arguello, YM | 1 |
| Bhaskarla, C; Das, M; Kumar, A; Mahadevan, S; Nandi, D; Verma, T | 1 |
| Lauková, A; Ščerbová, J | 1 |
| Albornoz, E; Andres, P; Centrón, D; Corso, A; Galas, M; Guerriero, L; Lucero, C; Petroni, A; Quiroga, MP; Rapoport, M; Rodriguez, C; Romero, G | 1 |
| Burgos, MJ; Fernández Márquez, ML; Gálvez, A; López, RL; Pulido, RP | 1 |
| Bayani, M; Ghaemi, EA; Hashemi, M; Khoshbakht, R; Raeisi, M; Seyedghasemi, NS; Shirzad-Aski, H | 1 |
| Changkaew, K; Changkwanyeun, R; Kongsoi, S; Nakajima, C; Pornruangwong, S; Siripanichgon, K; Suthienkul, O; Suzuki, Y; Tamura, Y; Tsunoda, R; Utrarachkij, F | 1 |
| De Silva, BCJ; Heo, GJ; Hossain, S; Pathirana, HNKS; Wimalasena, SHMP | 1 |
| Bakhshi, B; Douraghi, M; Fardsanei, F; Memariani, H; Nikkhahi, F; Soltan Dallal, MM; Zahraei Salehi, T | 1 |
| Balasundaram, P; Karuppasamy, R; Krishnamurthy, S; Veerappapillai, S | 1 |
| Batard, E; Caillon, J; Corvec, S; Lepelletier, D; Montassier, E; Pivette, J; Thibaut, S; Vibet, MA | 1 |
| Braetz, S; Fulde, M; Schwerk, P; Tedin, K; Thompson, A | 1 |
| Cha, SY; Choi, SW; Jang, HK; Kang, M; Wei, B | 1 |
| Mohan, B; Sethuraman, N; Taneja, N; Verma, R | 1 |
| Abulreesh, HH; Ahmad, I; Khan, JA; Qais, FA; Rathore, RS | 1 |
| Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B | 1 |
| Kowalska, J; Maćkiw, E; Mąka, Ł; Popowska, M; Postupolski, J; Stasiak, M; Wołkowicz, T | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Abdollahi, M; Ahanjan, M; Hashemi, B; Moghadaszadeh, M; Pormohammad, A; Rafiei, A; Rashidian, S | 1 |
| Expósito-Ruiz, M; Gutiérrez-Fernández, J; Guzmán-Martín, JL; Navarro-Marí, JM | 1 |
| Campioni, F; Costa, RG; Falcão, JP; Fernandes, SA; Gomes, CN; Passaglia, J; Rodrigues, DP; Tiba Casas, MR; Vilela, FP | 1 |
| Hidalgo, AA; Millanao, AR; Mora, AY; Mora, GC; Saavedra, CP; Valenzuela, LM; Villagra, NA | 1 |
| Bruinsma, N; Espinal, MA; Galas, M; Hsieh, J; Ramon Pardo, P; Sanhueza, A; Sati, HF | 1 |
| Alessiani, A; Di Donato, G; Di Giannatale, E; di Marcantonio, L; Di Serafino, G; Garofolo, G; Janowicz, A; Marotta, F; Neri, D; Nuvoloni, R; Romantini, R; Sacchini, L | 1 |
| Behzadi, P; Hozzari, A; Kerishchi Khiabani, P; Sabokroo, N; Sholeh, M | 1 |
| Bertrand, X; Bouxom, H; Gbaguidi-Haore, H; Jeanvoine, A; Leroy, J; Slekovec, C | 1 |
| Bao, C; Bao, J; Cheng, S; Dong, C; Gu, B; Hong, J; Jin, D; Liu, G; Qian, H; Tan, Z | 1 |
| Habeeb Rasool, K; Hammood Hussein, N; Mahamed Taha, B | 1 |
| Boqvist, S; Emanuelson, U; Fernström, LL; Frosth, S; Hansson, I; Tamminen, LM | 1 |
| Baltrus, DA; Clark, M; Derrick, M; Leligdon, C; Mollico, M; Moore, A; Rosenthal, Z; Smith, C | 1 |
| Dogan, A; Donmez, F | 1 |
| Catalá-Gregori, P; Cortés, V; García, C; Marín, C; Sevilla-Navarro, S | 1 |
| Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA | 1 |
| Aerts, M; Alvarez, J; Collado, S; de Frutos, C; Dominguez, L; Jaspers, S; Moreno, MA; Saez, JL; Teng, KT; Ugarte-Ruiz, M | 1 |
| Gunardi, WD; Moehario, LH; Nainggolan, IM; Nathania, I; Nusatia, ACM; Tjoa, E; Yasmon, A | 1 |
| Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
| Chaintoutis, SC; Lazou, TP | 1 |
| Chaleshtori, RS; Emami, MS; Rahimi, E; Shakerian, A | 1 |
| Feglo, PK; Sah, AK | 1 |
| Medina, AM; Ochoa, TJ; Pons, MJ; Rivera, FP; Riveros, M; Ruiz, J | 1 |
| AbuOun, M; Anjum, MF; Deza-Cruz, I; Smith, RP; Velasova, M; Vilar, MJ | 1 |
9 review(s) available for nalidixic acid and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Chelating Agents; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Structure-Activity Relationship; Triazoles | 2019 |
Quinolone antibiotics.
Topics: | 2019 |
Mechanisms of action of and resistance to ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Mutation; Nalidixic Acid; Norfloxacin; Topoisomerase II Inhibitors | 1987 |
Symposium on antimicrobial agents. The quinolones.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Humans; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
The mode of action of 4-quinolones and possible mechanisms of resistance.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
Quinolones in dermatology.
Topics: Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availability; Ciprofloxacin; Fluoroquinolones; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Skin Diseases; Structure-Activity Relationship | 2004 |
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.
Topics: Africa; Americas; Anti-Bacterial Agents; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Europe; Humans; Nalidixic Acid; Prevalence; Shigella flexneri; Shigella sonnei | 2012 |
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacterial; Furazolidone; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Norfloxacin; Novobiocin; Rifampin; Vibrio cholerae; Virulence Factors | 2022 |
3 trial(s) available for nalidixic acid and ciprofloxacin
| Article | Year |
|---|---|
[Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
Topics: Administration, Oral; Adult; Aminophylline; Asthma; Biological Availability; Ciprofloxacin; Drug Therapy, Combination; Humans; Middle Aged; Nalidixic Acid; Ofloxacin; Theophylline; Time Factors | 1992 |
Effect of quinolone antimicrobials on theophylline pharmacokinetics.
Topics: Adult; Ciprofloxacin; Half-Life; Humans; Male; Metabolic Clearance Rate; Nalidixic Acid; Norfloxacin; Random Allocation; Theophylline | 1989 |
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Marrow Diseases; Ciprofloxacin; Drug Therapy, Combination; Female; Granulocytes; Humans; Intestines; Leukocyte Count; Male; Middle Aged; Nalidixic Acid; Neomycin; Patient Compliance; Polymyxin B; Treatment Outcome | 1994 |
435 other study(ies) available for nalidixic acid and ciprofloxacin
| Article | Year |
|---|---|
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Antibacterial activity of quinolone-macrocycle conjugates.
Topics: Anti-Bacterial Agents; Escherichia coli; Heterocyclic Compounds; Microbial Sensitivity Tests; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2003 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; DNA Polymerase III; Drug Resistance, Bacterial; Gram-Positive Bacteria; Male; Mice; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests, Acute; Uracil | 2006 |
Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; DNA Fragmentation; DNA Gyrase; DNA, Bacterial; DnaB Helicases; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Models, Biological; Molecular Structure; Nalidixic Acid; Quinolones | 2007 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2007 |
Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacillus; Cell Line; Cell Survival; DNA Polymerase III; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Microbial Viability; Staphylococcus; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors; Uracil | 2007 |
First characterization of fluoroquinolone resistance in Streptococcus suis.
Topics: Amino Acid Sequence; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Molecular Sequence Data; Point Mutation; RNA, Ribosomal, 16S; Sequence Alignment; Streptococcus suis | 2007 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation | 2007 |
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Computer Simulation; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Amplification Techniques; Open Reading Frames; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Vibrio | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Plasmid-mediated quinolone resistance determinant QnrB4 identified in France in an Enterobacter cloacae clinical isolate coexpressing a QnrS1 determinant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia coli; France; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Quinolones; Transformation, Genetic | 2007 |
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bolivia; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Feces; Gene Transfer, Horizontal; Genetic Variation; Humans; Infant; Microbial Sensitivity Tests; Molecular Sequence Data; Peru; Plasmids; Poverty; Sequence Analysis, DNA; Time Factors | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Heat-Shock Proteins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Protease La; Pseudomonas aeruginosa | 2007 |
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
Topics: Anti-Bacterial Agents; Asia; Bangladesh; China; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Microbial; Fluoroquinolones; Humans; India; Indonesia; Laos; Microbial Sensitivity Tests; Mutation; Nepal; Pakistan; Salmonella typhi; Vietnam | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic | 2008 |
Novel variant of the qnrB gene, qnrB12, in Citrobacter werkmanii.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Citrobacter; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests | 2008 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Combinatorial Chemistry Techniques; Diamines; Escherichia coli; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Protein Biosynthesis; Pseudomonas aeruginosa; Structure-Activity Relationship | 2008 |
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cattle; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, Bacterial; Genes, MDR; Genetic Complementation Test; Humans; Molecular Sequence Data; Mutation; Phenotype; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Salmonella typhimurium | 2008 |
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Methyltransferases; Plasmids; RNA, Ribosomal, 16S; Swine; Swine Diseases | 2008 |
Alteration of GyrA amino acid required for ciprofloxacin resistance in Klebsiella pneumoniae isolates in China.
Topics: Amino Acid Substitution; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Quinolones | 2008 |
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plasmids; Quinolones | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Quinolones | 2008 |
ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli.
Topics: Base Sequence; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Quinolones | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Molecular Sequence Data; Sequence Homology, Amino Acid; Stenotrophomonas maltophilia | 2008 |
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators | 2008 |
Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
Topics: Amino Acid Substitution; Base Sequence; DNA Gyrase; DNA Mutational Analysis; DNA Primers; DNA Probes; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Streptococcus pneumoniae; Thermodynamics | 2008 |
Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals, University; Humans; Korea; Molecular Sequence Data; Quinolones; R Factors; Sequence Homology, Amino Acid | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Spain | 2009 |
qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Cattle; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Quinolones; Salmonella enterica | 2009 |
Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Chagas Disease; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Models, Chemical; Nitroimidazoles; Quinolones; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Synthesis and antibacterial property of quinolines with potent DNA gyrase activity.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2009 |
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Salmonella enteritidis; Trans-Activators | 2009 |
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacteria; Humans; Piperazines; Population Surveillance; Prodrugs | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
High prevalence of qnr genes in commensal enterobacteria from healthy children in Peru and Bolivia.
Topics: Bacterial Proteins; Base Sequence; Bolivia; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Infant; Klebsiella pneumoniae; Molecular Sequence Data; Peru; Plasmids; Polymerase Chain Reaction; Quinolones | 2009 |
Emergence of quinolone-resistant Bordetella pertussis in Japan.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Child; DNA Gyrase; Fluoroquinolones; Humans; Japan; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2009 |
First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Poultry; Poultry Diseases; Quinolones; Salmonella enterica | 2009 |
Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Microbial Sensitivity Tests; Multigene Family; Plasmids; Quinolones; Salmonella typhimurium | 2009 |
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines | 2009 |
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Electroporation; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial | 2010 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Caco-2 Cells; Ciprofloxacin; Conjugation, Genetic; DNA Gyrase; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Lipopolysaccharides; Microbial Sensitivity Tests; Microscopy, Electron; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Phenotype; Porins; Reverse Transcriptase Polymerase Chain Reaction; Salmonella enteritidis; Salmonella Infections | 2010 |
Transferable quinolone resistance in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Vibrio cholerae | 2010 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal enterobacteria.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotype; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; beta-Lactamases; Cephalosporin Resistance; Chickens; Disease Reservoirs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genes, Bacterial; Genetic Variation; Humans; Italy; Microbial Sensitivity Tests; Plasmids | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Novel variants of the qnrB gene, qnrB22 and qnrB23, in Citrobacter werkmanii and Citrobacter freundii.
Topics: Animals; Bacterial Proteins; Chickens; Citrobacter; Citrobacter freundii; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones; Swine | 2010 |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Drug Resistance, Bacterial; Finland; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Caenorhabditis elegans; Drug Resistance, Bacterial; Ertapenem; Klebsiella pneumoniae; Reverse Transcriptase Polymerase Chain Reaction; Virulence | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones | 2015 |
Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nalidixic Acid; Proteus vulgaris; Structure-Activity Relationship | 2015 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lipid Bilayers; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Phospholipids; Pyrazoles; Rabbits; Skin Irritancy Tests; Stereoisomerism; Structure-Activity Relationship; Uridine Monophosphate | 2017 |
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Quinolones; Topoisomerase II Inhibitors | 1991 |
Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Culture Media; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Serratia marcescens | 1991 |
Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antioxidants; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Free Radical Scavengers; Hemolysis; Male; Mice; Mice, Inbred Strains; Nalidixic Acid; Nitroso Compounds; Oxygen; Photochemistry; Photolysis; Quinolones; Thiobarbiturates | 1991 |
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Mutation; Nalidixic Acid; Phenotype; Quinolones; Serratia marcescens; Species Specificity | 1991 |
Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Topics: Cell Membrane Permeability; Chloramphenicol Resistance; Ciprofloxacin; DNA Topoisomerases, Type II; Escherichia coli; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Rifampin; RNA, Bacterial | 1991 |
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Culture Media; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Pseudomonas aeruginosa | 1991 |
Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Transformation, Bacterial | 1991 |
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
Topics: Adult; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Restriction Mapping | 1991 |
Role of the outer membrane for quinolone resistance in enterobacteria.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Lipopolysaccharides; Nalidixic Acid; Ofloxacin; Serratia marcescens; Species Specificity | 1990 |
Use of a non-radioactive DNA hybridization technique to study the effect of quinolone antibiotics on plasmid replication and curing.
Topics: Ampicillin Resistance; Biotin; Ciprofloxacin; DNA Probes; DNA, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Hybridization; Plasmids | 1990 |
Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies.
Topics: Adult; Aged; Aged, 80 and over; Animals; Candida albicans; Cells, Cultured; Ciprofloxacin; DNA; Female; Hemolysis; Histidine; Humans; Light; Lymphocytes; Macrophages; Male; Mice; Middle Aged; Nalidixic Acid; Photolysis; Photosensitivity Disorders | 1990 |
Loss of ciprofloxacin's second killing action in Escherichia coli that have developed 4-quinolone resistance during therapy.
Topics: Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Nalidixic Acid | 1990 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
DNA breakdown by the 4-quinolones and its significance.
Topics: Ciprofloxacin; DNA, Bacterial; Escherichia coli; Nalidixic Acid; Norfloxacin; Rifampin; SOS Response, Genetics; Species Specificity; Time Factors | 1990 |
[In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fleroxacin; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin | 1989 |
Interactions of the 4-quinolones with other antibacterials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin | 1989 |
Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Nalidixic Acid; Norfloxacin; Pseudomonas; Topoisomerase II Inhibitors | 1987 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Gentamicins; Humans; Metronidazole; Nalidixic Acid; Organometallic Compounds; Penicillin Resistance; Penicillins; Quinolines; Sulfamethoxazole; Tartrates; Trimethoprim | 1985 |
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
Topics: Acinetobacter; Bacteria; Bacterial Infections; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Quinolines; Serratia; Staphylococcus | 1986 |
Quinolones and colonization resistance in human volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Digestive System; Feces; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Inactivation of quinolone by feces.
Topics: Ciprofloxacin; Feces; Gram-Negative Bacteria; Humans; Intestines; Nalidixic Acid; Quinolines | 1986 |
The clinical use of quinolones.
Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Kinetics; Male; Micrococcus; Nalidixic Acid; Norfloxacin; Quinolines; Respiratory Tract Infections; Time Factors; Urologic Diseases | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines | 1985 |
Antimicrobial susceptibility of group B streptococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Quinolines; Streptococcus agalactiae; Thienamycins; Trimethoprim | 1986 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
In vitro studies of S-25930 and S-25932, two new 4-quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Edetic Acid; Enterobacteriaceae; Gram-Positive Bacteria; Humans; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines; Quinolizines | 1986 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
Population analysis of susceptibility to ciprofloxacin and nalidixic acid in Staphylococcus, Pseudomonas aeruginosa, and Enterobacteriaceae.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Staphylococcus | 1986 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
Topics: Anti-Bacterial Agents; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Polymyxin B; Pseudomonas aeruginosa; Quinolines | 1987 |
In vitro activity of PD 127,391, an enhanced-spectrum quinolone.
Topics: Anti-Infective Agents; Bacteria; Cefuroxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Ofloxacin | 1988 |
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Ciprofloxacin; Female; Fleroxacin; Genital Diseases, Female; Genital Diseases, Male; Male; Nalidixic Acid; Penicillins; Tetracyclines; Trimethoprim; Urinary Tract Infections | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens | 1985 |
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus | 1985 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Sensitivity Tests; Nalidixic Acid; Neutropenia; Pefloxacin; Pneumonia; Pseudomonas Infections; Quinolines; Time Factors | 1985 |
Cross resistance of quinolone derivatives in gram-negative bacteria.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Mutation; Nalidixic Acid; Nicotinic Acids; Oxolinic Acid; Pipemidic Acid; Quinolines | 1985 |
Antichlamydial activity of quinolone carboxylic acids.
Topics: Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Inhibition of conjugal transfer by new quinolinic compounds.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Quinolines; Quinolones | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Fluoroquinolones; Nalidixic Acid; Naphthyridines; Quinolines; Staphylococcus; Streptococcus | 1986 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
The response of Escherichia coli to ciprofloxacin and norfloxacin.
Topics: Cell Wall; Ciprofloxacin; Cytoplasm; Drug Resistance, Microbial; Escherichia coli; Microscopy, Electron; Microscopy, Electron, Scanning; Nalidixic Acid; Norfloxacin; Vacuoles | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
Topics: Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Structure-Activity Relationship | 1987 |
In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Quinolines | 1987 |
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors | 1984 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
Activities of newer quinolones against Legionella group organisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Legionella; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
Nalidixic acid analogues and Shigella.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Quinolines; Shigella | 1984 |
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Topics: Anti-Infective Agents, Urinary; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Quinolines | 1983 |
In vitro activity of ciprofloxacin (Bay o 9867).
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1983 |
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Cinoxacin; Ciprofloxacin; Humans; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Quinolines | 1984 |
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Protein Binding; Quinolines | 1984 |
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Humans; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Blood Proteins; Body Fluids; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Humans; Hydrogen-Ion Concentration; Nalidixic Acid; Norfloxacin; Protein Binding; Quinolines | 1984 |
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Micrococcaceae; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Quinolines | 1984 |
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Nalidixic Acid; Naphthyridines; Norfloxacin; Oxolinic Acid; Pseudomonas aeruginosa; Quinolines | 1984 |
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Drug Interactions; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
The in vitro and in vivo activity of ciprofloxacin.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Topics: 4-Quinolones; Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycoplasma; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Oxytetracycline; Quinolines; Quinolones; Ureaplasma | 1984 |
Mutational resistance to 4-quinolone antibacterial agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Humans; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Species Specificity | 1984 |
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Gastroenteritis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines; Salmonella; Shigella | 1984 |
In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Gardnerella vaginalis; Haemophilus; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In vitro activity of ciprofloxacin against group JK corynebacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Dose-Response Relationship, Drug; Humans; Nalidixic Acid; Norfloxacin; Quinolines | 1984 |
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones; Spectinomycin | 1984 |
Distribution of ciprofloxacin in the dog prostate and various tissues.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Dogs; Hydrogen-Ion Concentration; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Quinolines; Quinolones; Tissue Distribution | 1984 |
Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Nalidixic Acid; Quinolines | 1984 |
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1984 |
[Susceptibility to quinolones of Salmonella isolated from men and animals].
Topics: Animals; Anti-Infective Agents; Birds; Cattle; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; In Vitro Techniques; Male; Nalidixic Acid; Salmonella | 1995 |
A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Quinolones; Salmonella typhimurium | 1995 |
Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA Damage; DNA Repair; DNA, Bacterial; Escherichia coli; Mutation; Nalidixic Acid; Norfloxacin; Ofloxacin; RNA, Bacterial; SOS Response, Genetics | 1993 |
Detection of quinolone resistance in Haemophilus spp.
Topics: Ciprofloxacin; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid | 1994 |
Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces.
Topics: Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple; Erythromycin; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid | 1995 |
[Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
Topics: 4-Quinolones; Administration, Inhalation; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Lethal Dose 50; Mice; Nalidixic Acid; Pefloxacin; Plague; Quinolones | 1994 |
Quinolone resistance in veterinary isolates of Salmonella.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Lipopolysaccharides; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry Diseases; Quinolones; Salmonella; Salmonella Infections, Animal; Turkeys | 1994 |
Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
Topics: Animals; Anti-Infective Agents; Cartilage; Cell Survival; Cells, Cultured; Ciprofloxacin; Flow Cytometry; Free Radicals; Macrophages, Alveolar; Nalidixic Acid; Ofloxacin; Pefloxacin; Rabbits | 1994 |
[Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
Topics: Animals; Ciprofloxacin; Evaluation Studies as Topic; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin; Plague | 1993 |
An improved direct viable count for the enumeration of bacteria in milk.
Topics: Animals; Bacteria; Cell Division; Ciprofloxacin; Colony Count, Microbial; Food Microbiology; Milk; Mitomycin; Nalidixic Acid; Novobiocin | 1993 |
Interference of ofloxacin with determination of urinary porphyrins.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; False Positive Reactions; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Porphyrins; Spectrometry, Fluorescence | 1994 |
Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Injections, Intravenous; Male; Nalidixic Acid; Norfloxacin; Ofloxacin; Rats; Rats, Wistar | 1994 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
Cross-reactivity between quinolones. Report of three cases.
Topics: Adult; Anaphylaxis; Anti-Infective Agents; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Middle Aged; Nalidixic Acid; Pipemidic Acid | 1993 |
4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells.
Topics: Animals; Anti-Infective Agents; Cell Division; Ciprofloxacin; DNA, Mitochondrial; DNA, Neoplasm; Lactates; Lactic Acid; Leukemia L1210; Mice; Mitochondria; Models, Genetic; Nalidixic Acid; Oxygen Consumption; Tumor Cells, Cultured | 1993 |
Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
Topics: Amino Acid Sequence; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella typhi | 1996 |
Lack of effects of ciprofloxacin and the topoisomerase II inhibitors, m-AMSA and nalidixic acid, on DNA repair in cultured rat liver cells.
Topics: Amsacrine; Animals; Autoradiography; Cells, Cultured; Ciprofloxacin; DNA Repair; DNA Topoisomerases, Type II; Liver; Male; Mutagenicity Tests; Nalidixic Acid; Rats; Rats, Inbred F344; Topoisomerase II Inhibitors | 1996 |
A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Escherichia coli; Genetic Complementation Test; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Nalidixic Acid; Sequence Analysis, DNA | 1997 |
False-positive EMIT II opiates from ofloxacin.
Topics: Anti-Infective Agents; Antibodies; Ciprofloxacin; Cross Reactions; Enzyme Multiplied Immunoassay Technique; False Positive Reactions; Humans; Morphine; Nalidixic Acid; Norfloxacin; Ofloxacin | 1997 |
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Cephalosporins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutation; Nalidixic Acid; Polymerase Chain Reaction | 1997 |
Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fleroxacin; Fluoroquinolones; Mice; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Quinolones; Skin Neoplasms; Ultraviolet Rays | 1997 |
Quinolone antibacterials: a new class of photochemical carcinogens.
Topics: Animals; Anti-Infective Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Dermatitis, Phototoxic; Fleroxacin; Fluoroquinolones; Methoxsalen; Mice; Mice, Hairless; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Papilloma; Quinolones; Skin Neoplasms | 1997 |
Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Blastocystis hominis; Blastocystis Infections; Chloramphenicol Resistance; Ciprofloxacin; Cryptosporidiosis; Diarrhea; Dientamoebiasis; Dysentery, Amebic; Egypt; Entamoeba; Entamoeba histolytica; Escherichia coli; Escherichia coli Infections; Eukaryota; Fimbriae Proteins; Humans; Military Personnel; Nalidixic Acid; Norfloxacin; Pili, Sex; Protozoan Infections; Tetracycline Resistance; United States | 1997 |
Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Feces; Humans; Molecular Sequence Data; Mutation; Nalidixic Acid; Salmonella Infections; Salmonella typhimurium; Spain | 1997 |
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Interactions; Drug Synergism; Escherichia coli; HIV-1; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pyelitis; Salmonella Infections; Salmonella typhimurium; SOS Response, Genetics; Zidovudine | 1998 |
Quinolone resistance from a transferable plasmid.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Klebsiella pneumoniae; Nalidixic Acid; Plasmids | 1998 |
Susceptibility of different isolates of Vibrio harveyi to antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Decapoda; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fish Diseases; Fishes; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Novobiocin; Oxolinic Acid; Oxytetracycline; Penicillins; Seawater; Streptomycin; Sulfonamides; Vancomycin; Vibrio; Vibrio Infections; Water Microbiology | 1997 |
[Campylobacter spp. in the surroundings of poultry meat production-- incidence and chinolone resistance].
Topics: Abattoirs; Animals; Anti-Infective Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; Drug Resistance, Microbial; Humans; Meat; Nalidixic Acid; Poultry | 1998 |
Comparative genotoxicity of quinolone and quinolonyl-lactam antibacterials in the in vitro micronucleus assay in Chinese hamster ovary cells.
Topics: Animals; Anti-Infective Agents; CHO Cells; Ciprofloxacin; Cricetinae; Micronucleus Tests; Mutagens; Nalidixic Acid; Topoisomerase II Inhibitors | 1998 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada.
Topics: Campylobacter jejuni; Canada; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline; Time Factors | 1998 |
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Quinolones | 1998 |
[Quinolone resistance in Salmonella enterica].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Feces; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica; Serotyping | 1998 |
Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Bacterial Typing Techniques; Campylobacter Infections; Campylobacter jejuni; Case-Control Studies; Chickens; Ciprofloxacin; Drug Resistance, Microbial; Humans; Meat; Minnesota; Nalidixic Acid; Population Surveillance; Risk Factors; Travel | 1999 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Selection of resistant variants of respiratory pathogens by quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Nalidixic Acid; Ofloxacin; Pneumonia, Bacterial; Streptococcus pneumoniae | 1999 |
Risk factors for death in hospitalized dysentery patients in Rwanda.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Dysentery, Bacillary; Female; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Nalidixic Acid; Prospective Studies; Risk Factors; Rwanda; Shigella dysenteriae; Surveys and Questionnaires; Treatment Outcome | 1999 |
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Reproducibility of Results; Salmonella; Salmonella Infections | 1999 |
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Citrobacter freundii; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Polymerase Chain Reaction | 1999 |
Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; England; Erythromycin; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Wales | 1999 |
[Evolution of resistance to quinolones in Salmonella enterica in our setting].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica | 1999 |
Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
Topics: Anti-Infective Agents; Chromosomes, Bacterial; Ciprofloxacin; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Kinetics; Macromolecular Substances; Nalidixic Acid; Norfloxacin; Staphylococcus aureus; Topoisomerase II Inhibitors | 2000 |
Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Resistance, Microbial; Lipopolysaccharides; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Salicylates; Serratia marcescens | 2000 |
Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
Topics: Anti-Infective Agents; Base Sequence; Campylobacter coli; Campylobacter Infections; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Polymerase Chain Reaction; Sequence Analysis, DNA | 2000 |
A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Blotting, Northern; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Plasmids; Salmonella enterica; Salmonella Infections; Tetracyclines | 2001 |
High rate of resistance to nalidixic acid in Salmonella enterica: its role as a marker of resistance to fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica; Salmonella enteritidis; Salmonella typhimurium | 2000 |
Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Humans; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica; Serotyping | 2001 |
Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys.
Topics: Amino Acid Substitution; Animals; Anti-Infective Agents; Bacterial Proteins; Blotting, Western; Carrier Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Nalidixic Acid; Quinolizines; Quinolones; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Turkeys | 2001 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
Topics: Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Enrofloxacin; Escherichia coli; Fluoroquinolones; Goats; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Ruminants; Sheep | 2001 |
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Hospitals, University; Humans; Microbial Sensitivity Tests; Nalidixic Acid | 2001 |
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Topics: Anti-Infective Agents; Aza Compounds; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Nalidixic Acid; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Netilmicin; Norfloxacin; Prevalence; Time Factors | 2002 |
Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Reserpine | 2002 |
Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.
Topics: Animals; Animals, Domestic; Anti-Infective Agents; Ciprofloxacin; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; England; Integrases; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections, Animal; Wales | 2002 |
High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Escherichia coli; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype | 2002 |
Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2001 |
Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Staphylococcus aureus | 2002 |
Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Survival Rate | 2002 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Are quinolone-resistant uropathogenic Escherichia coli less virulent?
Topics: Anti-Infective Agents; Bacterial Toxins; Ciprofloxacin; Cystitis; Cytotoxins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fimbriae, Bacterial; Hemolysin Proteins; Humans; Nalidixic Acid; Pyelonephritis; Urinary Tract Infections; Virulence | 2002 |
Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; DNA Gyrase; DNA Mutational Analysis; DNA Probes; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Polymorphism, Single-Stranded Conformational; Salmonella enterica; Sequence Analysis, DNA; Time Factors | 2002 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2003 |
Determination of ciprofloxacin and nalidixic acid resistance in Campylobacter jejuni with a fluorogenic polymerase chain reaction assay.
Topics: Abattoirs; Animals; Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction | 2003 |
Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Vibrio cholerae O1; Vibrio cholerae O139 | 2002 |
Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the mid-west region of the Republic of Ireland.
Topics: Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Ireland; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Salmonella Infections; Swine | 2003 |
Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; United Kingdom | 2003 |
Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Topics: Adult; Bangladesh; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Treatment Failure; Typhoid Fever | 2003 |
Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, Canada.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quebec; Tetracycline | 2003 |
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Genes, Bacterial; Gonorrhea; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Nalidixic Acid; Naphthyridines; Neisseria gonorrhoeae; Ofloxacin; Quinolines | 2003 |
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2003 |
Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
Topics: Alkylating Agents; beta-Galactosidase; Ciprofloxacin; DNA Damage; DNA, Bacterial; DNA, Superhelical; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Genes, Reporter; Methylnitronitrosoguanidine; Mitomycin; Mutagenesis; Nalidixic Acid; Plasmids; Quinolones; Repressor Proteins; SOS Response, Genetics; Topoisomerase II Inhibitors; Ultraviolet Rays | 2003 |
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction; Sepsis | 2003 |
In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance.
Topics: Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica | 2003 |
Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Colony Count, Microbial; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Incidence; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry; Quinolones; Salmonella; Salmonella Infections, Animal; Serotyping; Swine | 2003 |
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
Topics: Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Urinary Tract Infections | 2004 |
Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections; Swine | 2004 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Topics: Aza Compounds; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Topoisomerase IV; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction; Quinolines | 2004 |
Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Predictive Value of Tests; Salmonella; Salmonella Infections; Sensitivity and Specificity; Serotyping | 2004 |
Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Dipeptides; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Spain; Yersinia enterocolitica; Yersinia Infections | 2004 |
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Base Pair Mismatch; Chloramphenicol; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Probes; DNA Repair; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Polymorphism, Single Nucleotide; Quinolones; Salmonella enterica; Salmonella Infections | 2004 |
Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Saudi Arabia; Shigella sonnei | 2004 |
Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
Topics: Amino Acid Substitution; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Hospitals, University; Microbial Sensitivity Tests; Mutation, Missense; Nalidixic Acid; Salmonella enterica; Spain | 2004 |
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Topics: Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Paratyphoid Fever; Retrospective Studies; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2004 |
Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Food Microbiology; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Salmonella typhimurium; Spain | 2004 |
Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Blood Chemical Analysis; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Risk Assessment; Salmonella typhi; Sampling Studies; Saudi Arabia; Severity of Illness Index; Treatment Outcome; Typhoid Fever | 2004 |
Antibiotics in the management of shigellosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Humans; Nalidixic Acid; Shigella | 2004 |
International note. Antibiotics in the management of shigellosis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Nalidixic Acid; Shigella | 2004 |
Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains.
Topics: Animals; Campylobacter hyointestinalis; Cattle; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Reindeer | 2005 |
Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina.
Topics: Anti-Bacterial Agents; Argentina; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Nalidixic Acid; Neisseria meningitidis | 2005 |
Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Salmonella; Salmonella Infections | 2005 |
Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Topics: Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2005 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2005 |
Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Serotyping; Time Factors | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
Nalidixic acid-susceptible, ciprofloxacin-resistant Neisseria gonorrhoeae strain in the UK.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; United Kingdom | 2005 |
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Treatment Failure; Typhoid Fever | 2005 |
Antimicrobial resistance patterns of Campylobacter from feedlot cattle*.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.
Topics: Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Hemolysis; Humans; Nalidixic Acid; Virulence Factors | 2005 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2005 |
Current perspectives of enteric fever: a hospital-based study from India.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Retrospective Studies; Risk Factors; Salmonella paratyphi A; Salmonella typhi; Seasons; Serotyping; Sex Distribution; Typhoid Fever | 2005 |
Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriophage Typing; Ciprofloxacin; DNA Fingerprinting; DNA Topoisomerases; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Korea; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Nalidixic Acid; Organic Chemicals; Random Amplified Polymorphic DNA Technique; Salmonella enterica; Salmonella Infections; Serotyping; Solvents | 2005 |
Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genotype; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Virulence Factors | 2005 |
Typhoid and paratyphoid fever.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nepal; Ofloxacin; Salmonella enterica | 2005 |
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
Topics: Anti-Infective Agents; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Quinolones; Salmonella enterica; Salmonella Infections; Travel | 2005 |
Virulence factors in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Nalidixic Acid; Virulence Factors | 2005 |
Characterization of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ireland; Multidrug Resistance-Associated Proteins; Nalidixic Acid; Operon; Quinolones | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Genetic characterization and antibiotic resistance of Campylobacter spp. isolated from poultry and humans in Senegal.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Food Microbiology; Genes, Bacterial; Genetic Variation; Genotype; Humans; Nalidixic Acid; Poultry; Quinolones | 2006 |
Resistance to three antimicrobial agents of Campylobacter isolated from organically- and intensively-reared chickens purchased from retail outlets.
Topics: Animal Husbandry; Animals; Campylobacter; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Food, Organic; Meat; Microbial Sensitivity Tests; Nalidixic Acid; United Kingdom | 2006 |
In-situ enumeration and probing of pyrene-degrading soil bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Biodegradation, Environmental; Ciprofloxacin; Colony Count, Microbial; Culture Media; DNA, Bacterial; In Situ Hybridization, Fluorescence; Indoles; Nalidixic Acid; Piromidic Acid; Pyrenes; Soil Microbiology; Staining and Labeling | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Bacterial Proteins; Campylobacter; Campylobacter coli; Campylobacter jejuni; Cattle; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Mutation, Missense; Nalidixic Acid; Point Mutation | 2006 |
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344 | 2006 |
Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Sensitivity and Specificity; Serotyping; Treatment Outcome; Turkey | 2006 |
Genetic diversity and quinolone resistance in Campylobacter jejuni isolates from poultry in Senegal.
Topics: Animals; Anti-Infective Agents; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genetic Variation; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry; Quinolones; Senegal | 2006 |
Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genes, Bacterial; Nalidixic Acid; Plasmids; Quinolones; Salmonella enterica | 2006 |
The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Salmonella typhi | 2006 |
Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Topics: Biomarkers; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi | 2006 |
Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.
Topics: Anti-Bacterial Agents; Aspirin; Aza Compounds; Ciprofloxacin; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Moxifloxacin; Mutation; Nalidixic Acid; Operon; Quinolines; Salmonella | 2006 |
Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004.
Topics: Ampicillin; Animals; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; England; Food Microbiology; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enteritidis; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhimurium; Serotyping; Tetracyclines; Travel; Veterinary Drugs; Wales; Zoonoses | 2006 |
Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Salmonella enterica; Salmonella Infections; Sentinel Surveillance; United States | 2007 |
Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; HIV Infections; Humans; India; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2007 |
[Decrease in bactericidal activity of ciprofloxacin in Salmonella mutants generated following repeated exposure to various fluorquinolones].
Topics: Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Resistance; Fluoroquinolones; Nalidixic Acid; Salmonella; Salmonella enteritidis; Salmonella typhimurium; Selection, Genetic | 2006 |
Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Paratyphoid Fever; Salmonella paratyphi A; Treatment Failure | 2007 |
Campylobacter coli isolates derived from chickens in Senegal: Diversity, genetic exchange with Campylobacter jejuni and quinolone resistance.
Topics: Alleles; Animals; Anti-Infective Agents; Campylobacter coli; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genetic Variation; Nalidixic Acid; Polymerase Chain Reaction; Quinolones; Senegal | 2007 |
Resistance to quinolones in Salmonella infantis due to overexpression of an active efflux system and a mutation in the gyrA gene.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Salmonella enterica; Salmonella Infections | 2007 |
Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pilot Projects; Salmonella enterica; Salmonella Infections; Sentinel Surveillance; Thailand | 2007 |
Prevalence and antimicrobial resistance of Campylobacter in US dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Cattle Diseases; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Nalidixic Acid; Prevalence; Tetracycline; United States | 2007 |
Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nepal; Salmonella typhi; Typhoid Fever | 2007 |
Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Chickens; Ciprofloxacin; Cloning, Molecular; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Point Mutation; Poultry Diseases; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Salmonella enterica serovar typhi: molecular analysis of strains with decreased susceptibility and resistant to ciprofloxacin in India from 2001-2003.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Polymerase Chain Reaction; Salmonella typhi | 2007 |
Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Bacterial; Female; Humans; Intestinal Obstruction; Mesenteric Lymphadenitis; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2008 |
Optimization of the use of ciprofloxacin.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Amplification; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction | 2009 |
Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Topics: Animals; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry | 2008 |
Low-level quinolone-resistance in multi-drug resistant typhoid.
Topics: Anti-Infective Agents; Antimalarials; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Pilot Projects; Quinidine; Salmonella typhi; Typhoid Fever | 2008 |
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Prevalence; Quinolones; Swine; Swine Diseases | 2008 |
Quinolone-resistant Escherichia coli.
Topics: Anti-Infective Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Male; Mutation; Nalidixic Acid; Norfloxacin | 2008 |
[Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; beta-Lactamases; Cephalosporin Resistance; Cephalothin; Child; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Shigella sonnei; Staphylococcus aureus | 2008 |
Contamination of chicken meat with Salmonella enterica Serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility.
Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Food Contamination; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2008 |
Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Finland; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica; Salmonella Infections; Serotyping; Travel | 2009 |
Spread of Serratia marcescens coharboring aac(6')-Ib-cr, bla CTX-M, armA, and bla OXA-1 carried by conjugative IncL/M type plasmid in Korean hospitals.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals; Humans; Korea; Nalidixic Acid; Plasmids; Serratia Infections; Serratia marcescens | 2009 |
Effect of analgesics and their derivatives on antibiotic resistance of environmental microbes.
Topics: Amino Acid Sequence; Analgesics; Anti-Bacterial Agents; Aspirin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Nitrosomonas europaea; Salicylic Acid; Salmonella enterica; Sequence Homology, Amino Acid | 2009 |
Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
Topics: Amino Acid Sequence; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Mutant Proteins; Mutation; Nalidixic Acid; Protein Binding | 2009 |
Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007.
Topics: Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Prevalence; Salmonella typhi; South Africa; Typhoid Fever | 2010 |
Antimicrobial resistance of Campylobacter species isolated from edible bivalve molluscs purchased from Bangkok markets, Thailand.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Food Handling; Food Microbiology; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Mollusca; Nalidixic Acid; Shellfish; Thailand | 2009 |
Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones; Salmonella; Salmonella Infections; Travel | 2009 |
High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Male; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Typhoid Fever; Young Adult | 2009 |
Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; HeLa Cells; Humans; Models, Genetic; Mutation; Nalidixic Acid; Neoplasm Invasiveness; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Salmonella typhimurium; Transcription, Genetic | 2009 |
Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones.
Topics: Anti-Bacterial Agents; Bartonella bacilliformis; Bartonella Infections; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Nalidixic Acid; Quinolones; Sequence Analysis, Protein; Spain | 2010 |
Inhibition of photosynthesis by a fluoroquinolone antibiotic.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Molecular Structure; Nalidixic Acid; Photosynthesis; Spinacia oleracea | 2010 |
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Typhoid Fever | 2010 |
[Salmonella spp. strains resistant to drugs].
Topics: Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Nalidixic Acid; Poland; Retrospective Studies; Salmonella; Species Specificity | 2010 |
Characterization of quinolone resistance in Escherichia coli strains of animal origin from Italy.
Topics: Animals; Anti-Infective Agents; Blotting, Southern; Cattle; Chickens; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Italy; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Rabbits; Sheep | 2010 |
In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.
Topics: Bacterial Proteins; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Salmonella paratyphi A | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Ofloxacin; Randomized Controlled Trials as Topic; Recurrence; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2010 |
Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009.
Topics: Anti-Bacterial Agents; Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella Infections; Salmonella typhimurium; Slovakia | 2010 |
Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Salmonella typhi | 2010 |
Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Gastroenteritis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Quinolones; Salmonella; Salmonella Infections; Sequence Analysis, DNA; Spain | 2010 |
Occurrence of Helicobacter pullorum in turkeys.
Topics: Abattoirs; Amplified Fragment Length Polymorphism Analysis; Animals; Anti-Bacterial Agents; Cecum; Ciprofloxacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genotype; Helicobacter; Helicobacter Infections; Italy; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Polymerase Chain Reaction; Poultry Diseases; Turkeys | 2011 |
Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enterica; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Travel; United Kingdom | 2011 |
Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asia, Southeastern; Blood; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Paratyphoid Fever; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2011 |
A quantitative approach to analyse linkages between antimicrobial resistance properties in Salmonella Typhimurium isolates.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Data Interpretation, Statistical; Drug Resistance, Multiple, Bacterial; Female; Germany; Humans; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Statistics, Nonparametric | 2012 |
[Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lethal Dose 50; Levofloxacin; Mice; Models, Animal; Nalidixic Acid; Ofloxacin; Plague; Virulence; Yersinia pestis | 2010 |
Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Denmark; DNA Topoisomerases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Urinary Tract Infections | 2011 |
Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Profiling; Ireland; Membrane Transport Proteins; Microbial Sensitivity Tests; Nalidixic Acid; Sequence Analysis, DNA | 2011 |
The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.
Topics: Anti-Infective Agents; Bacterial Proteins; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutation; Nalidixic Acid; Promoter Regions, Genetic; Proton Ionophores; Reverse Transcriptase Polymerase Chain Reaction; Salmonella typhimurium; Trans-Activators | 2011 |
In vivo sequential selection of Escherichia coli with topoisomerase- and efflux-mediated misleading quinolone resistance phenotypes.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type I; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Phenotype; Quinolones; Selection, Genetic; Sequence Analysis, DNA | 2012 |
[Prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr among ESBL producing enterobacteria isolates from Chilean hospitals].
Topics: Acetylation; Anti-Bacterial Agents; Bacterial Proteins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Ofloxacin; Polymorphism, Restriction Fragment Length; R Factors; Sequence Analysis, DNA; Substrate Specificity | 2012 |
Incidence and antimicrobial resistance profiling of Campylobacter in retail chicken livers and gizzards.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Chloramphenicol; Ciprofloxacin; Clindamycin; Colony Count, Microbial; DNA, Bacterial; Doxycycline; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Gizzard, Avian; Incidence; Liver; Meat Products; Microbial Sensitivity Tests; Nalidixic Acid; Oklahoma; Tetracycline | 2012 |
Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nepal; Polymerase Chain Reaction; Salmonella typhi; Sensitivity and Specificity; Typhoid Fever | 2012 |
Antibiotic susceptibility profile of Aeromonas species isolated from wastewater treatment plant.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Polymerase Chain Reaction; Prevalence; South Africa; Wastewater; Water Microbiology | 2012 |
Functional characterization of quinolone-resistant mechanisms in a lab-selected Salmonella enterica typhimurium mutant.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Quinolones; Salmonella enterica; Salmonella typhimurium | 2013 |
Extraintestinal pathogenic Escherichia coli in poultry meat products on the Finnish retail market.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Chickens; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Finland; Genotyping Techniques; Meat Products; Nalidixic Acid; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Prevalence; Turkeys; Virulence; Zoonoses | 2012 |
Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; Cluster Analysis; DNA Gyrase; DNA Mutational Analysis; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Phylogeny; Prevalence; Quinolones; R Factors; Republic of Korea; Swine; Swine Diseases | 2012 |
[Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Poland; Species Specificity | 2012 |
Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Water Microbiology | 2013 |
Prevalence and characterization of plasmid-mediated quinolone resistance genes in Salmonella isolated from poultry in Korea.
Topics: Animals; Blotting, Southern; Ciprofloxacin; DNA Primers; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Gene Transfer, Horizontal; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Poultry; Poultry Diseases; Quinolones; Republic of Korea; Salmonella; Salmonella Infections, Animal | 2013 |
Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plankton; Proteus mirabilis; Quinolones | 2013 |
Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella paratyphi A; Salmonella typhi; Tertiary Healthcare; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2013 |
Prevalence and antimicrobial resistance of Campylobacter spp. isolated from poultry carcasses in Poland.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Consumer Product Safety; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Humans; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Poland; Poultry; Prevalence; Tetracycline | 2013 |
SbcCD-mediated processing of covalent gyrase-DNA complex in Escherichia coli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Deoxyribonucleases; DNA Gyrase; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Exonucleases; Nalidixic Acid | 2013 |
Fever of unknown origin attributable to haematocolpos infected with Salmonella enterica Serotypetyphi resistant to nalidixic acid: a case report.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Bacterial; Female; Fever of Unknown Origin; Hematocolpos; Humans; Metronidazole; Nalidixic Acid; Salmonella typhi | 2013 |
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Peru; Prevalence; Quinolones | 2014 |
Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Humans; Integrons; Nalidixic Acid; Phylogeny; Prevalence; Shigella sonnei; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Molecular epidemiology of Salmonella enterica serovar Kottbus isolated in Germany from humans, food and animals.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Food Microbiology; Germany; Humans; Meat; Microbial Sensitivity Tests; Molecular Epidemiology; Nalidixic Acid; Poultry; Prevalence; Salmonella enterica; Salmonella Infections; Virulence Factors | 2014 |
Prevalence and characterisation of quinolone resistance mechanisms in Salmonella spp.
Topics: Amino Acid Substitution; Animal Feed; Animals; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Poland; Prevalence; Quinolones; Salmonella; Salmonella Infections, Animal; Species Specificity | 2014 |
Persistence of fluoroquinolone-resistant Salmonella enterica serovar Kentucky from poultry and poultry sources in Nigeria.
Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Feces; Fluoroquinolones; Genotype; Microbial Sensitivity Tests; Molecular Typing; Nalidixic Acid; Nigeria; Poultry Diseases; Salmonella enterica; Salmonella Infections, Animal | 2014 |
Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Real-Time Polymerase Chain Reaction; Salmonella Infections; Salmonella typhimurium; Selection, Genetic; Serial Passage | 2014 |
Synthetic interaction between the TipN polarity factor and an AcrAB-family efflux pump implicates cell polarity in bacterial drug resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Caulobacter crescentus; Cell Polarity; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Structure-Activity Relationship | 2014 |
Polarity factors play a role in antibiotic resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Caulobacter crescentus; Cell Polarity; Ciprofloxacin; Drug Resistance, Bacterial; Nalidixic Acid | 2014 |
High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norway; Phylogeny; Quinolones; Species Specificity; Urinary Tract | 2014 |
Lactococcus garvieae carries a chromosomally encoded pentapeptide repeat protein that confers reduced susceptibility to quinolones in Escherichia coli producing a cytotoxic effect.
Topics: Anti-Bacterial Agents; Cell Membrane; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gene Expression; Lactococcus; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nalidixic Acid; Quinolones; Recombinant Proteins | 2014 |
Detection of plasmid-mediated qnr genes among the quinolone-resistant Escherichia coli isolates in Iran.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Iran; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones; Urinary Tract Infections | 2014 |
Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam.
Topics: Anti-Bacterial Agents; Bangladesh; Base Sequence; Carrier Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Indonesia; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Salmonella typhi; Sequence Analysis, DNA; Taiwan; Typhoid Fever; Vietnam | 2014 |
Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genetic Variation; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Nalidixic Acid; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Sequence Analysis, DNA | 2015 |
Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
Topics: Anti-Bacterial Agents; Biological Transport, Active; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Models, Molecular; Mutation, Missense; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction; Protein Conformation; Quinolones; Seafood; Selection, Genetic; Sequence Analysis, DNA | 2015 |
[Salmonella enterica with nonclassical quinolone resistance phenotype in pediatric patients].
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections | 2015 |
[Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Breaks, Double-Stranded; DNA Helicases; DNA Repair; DNA Replication; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Exodeoxyribonuclease V; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Targeted Therapy; Nalidixic Acid; Norfloxacin; Quinolones; Rec A Recombinases; Recombinational DNA Repair; Serine Endopeptidases; SOS Response, Genetics | 2015 |
Environmental phosphate differentially affects virulence phenotypes of uropathogenic Escherichia coli isolates causative of prostatitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cellulose; Ciprofloxacin; Escherichia coli Infections; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Phosphates; Prostatitis; Uropathogenic Escherichia coli; Virulence; Virulence Factors | 2015 |
Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Topics: Bangladesh; Cholera; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Humans; Male; Nalidixic Acid; Randomized Controlled Trials as Topic; Retrospective Studies; Vibrio cholerae | 2015 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Nalidixic Acid; Ofloxacin; Pefloxacin; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA | 2015 |
Quinolone Resistance Mechanisms Among Salmonella enterica in Malaysia.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Malaysia; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Prevalence; Quinolones; Salmonella enterica; Salmonella Infections | 2016 |
Fluoroquinolone and macrolide resistance in Campylobacter jejuni isolated from broiler slaughterhouses in southern Brazil.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Brazil; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Nalidixic Acid; Polymorphism, Restriction Fragment Length; Poultry Diseases | 2016 |
Roles of Lon protease and its substrate MarA during sodium salicylate-mediated growth reduction and antibiotic resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Microscopy, Atomic Force; Multidrug Resistance-Associated Proteins; Nalidixic Acid; Protease La; Sodium Salicylate; Tetracycline; Tetracycline Resistance | 2016 |
Sensitivity to Enterocins of Thermophilic Campylobacter spp. from Different Poultry Species.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteriocins; Campylobacter coli; Campylobacter jejuni; Chickens; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Ducks; Enterococcus faecium; Feces; Female; Male; Molecular Typing; Nalidixic Acid; Slovakia; Struthioniformes | 2016 |
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Prevalence; Quinolones | 2017 |
Biocide Tolerance and Antibiotic Resistance in Salmonella Isolates from Hen Eggshells.
Topics: Animals; Anti-Bacterial Agents; Benzalkonium Compounds; Ceftazidime; Chickens; Chloramphenicol; Ciprofloxacin; Disinfectants; Drug Resistance, Multiple, Bacterial; Egg Shell; Food Contamination; Food Microbiology; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Salmonella enterica; Streptomycin; Tetracycline | 2017 |
Antimicrobial Resistance and Virulence-Associated Genes of Campylobacter spp. Isolated from Raw Milk, Fish, Poultry, and Red Meat.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Cattle; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fishes; Food Microbiology; Gene Expression; Genes, Bacterial; Genotype; Humans; Meat; Microbial Sensitivity Tests; Milk; Nalidixic Acid; Polymerase Chain Reaction; Poultry; Sheep; Tetracycline; Virulence | 2017 |
Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clone Cells; DNA Gyrase; Drug Resistance, Bacterial; Gene Expression; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Nalidixic Acid; Norfloxacin; Phylogeny; Plasmids; Prevalence; Salmonella enteritidis; Salmonella Infections; Thailand | 2017 |
Prevalence and characterisation of quinolone resistance genes in Aeromonas spp. isolated from pet turtles in South Korea.
Topics: Aeromonas; Amino Acid Substitution; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Plasmids; Polymerase Chain Reaction; Quinolones; Republic of Korea; Turtles | 2017 |
Antimicrobial resistance, virulence genes and genetic relatedness of Salmonella enterica serotype Enteritidis isolates recovered from human gastroenteritis in Tehran, Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Gastroenteritis; Humans; Iran; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Salmonella enteritidis; Salmonella Infections; Virulence Factors | 2018 |
Drug repurposing: An approach to tackle drug resistance in S. typhimurium.
Topics: Bacterial Proteins; Ciprofloxacin; Databases, Factual; DNA Gyrase; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Flufenamic Acid; Molecular Dynamics Simulation; Nalidixic Acid; Quinolones; Salmonella typhimurium; Topoisomerase II Inhibitors | 2018 |
Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Retrospective Studies; Tetracycline | 2018 |
The role of ATP pools in persister cell formation in (fluoro)quinolone-susceptible and -resistant strains of Salmonella enterica ser. Typhimurium.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Mutation; Nalidixic Acid; Quinolones; Salmonella Infections, Animal; Salmonella typhimurium | 2017 |
Molecular Characterization of Fluoroquinolone Resistance Mechanisms of Campylobacter Isolates from Duck Meats.
Topics: Animals; Campylobacter; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ducks; Fluoroquinolones; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolines; Quinolones | 2017 |
Speciation, clinical profile & antibiotic resistance in
Topics: Adolescent; Adult; Aeromonas; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Female; Humans; India; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Retrospective Studies; Tertiary Care Centers; Young Adult | 2017 |
Prevalence and Antibiotic Resistance Profiles of Campylobacter jejuni Isolated from Poultry Meat and Related Samples at Retail Shops in Northern India.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter jejuni; Cephalothin; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Food Contamination; Food Microbiology; India; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Public Health; Tetracycline | 2018 |
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; India; Male; Microbial Sensitivity Tests; Nalidixic Acid; Recurrence; Salmonella typhi; Treatment Outcome; Typhoid Fever; Young Adult | 2018 |
Ciprofloxacin and nalidixic acid resistance of Salmonella spp. isolated from retail food in Poland.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Food Microbiology; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Poland; Salmonella | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Female; Fluoroquinolones; Humans; Iran; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational | 2018 |
Nalidixic acid surrogate test for susceptibility to ciprofloxacin in
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Salmonella Infections; Serogroup | 2018 |
Genotypic Resistance to Quinolone and Tetracycline in Salmonella Dublin Strains Isolated from Humans and Animals in Brazil.
Topics: Animals; Anti-Bacterial Agents; Brazil; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica; Tetracycline | 2019 |
Cysteine auxotrophy drives reduced susceptibility to quinolones and paraquat by inducing the expression of efflux-pump systems and detoxifying enzymes in S. Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cysteine; Drug Resistance, Multiple, Bacterial; Gene Deletion; Gene Expression; Genes, Bacterial; Humans; Levofloxacin; Membrane Transport Proteins; Mutation; Nalidixic Acid; Paraquat; Quinolones; Reactive Oxygen Species; Salmonella typhimurium; Sulfur | 2019 |
Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Latin America; Microbial Sensitivity Tests; Nalidixic Acid; Shigella | 2019 |
Antimicrobial resistance genotypes and phenotypes of Campylobacter jejuni isolated in Italy from humans, birds from wild and urban habitats, and poultry.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Birds; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Italy; Nalidixic Acid; Poultry; Species Specificity; Tetracycline; Urban Renewal | 2019 |
Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli.
Topics: Bacterial Toxins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Hemolysin Proteins; Humans; Membrane Proteins; Nalidixic Acid; Penicillins; Streptomycin; Tetracycline; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence; Virulence Factors | 2020 |
Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; France; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Outpatients; Prevalence; Retrospective Studies | 2020 |
Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Salmonella paratyphi A; Salmonella typhi | 2020 |
Molecular Detection of
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cefepime; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Inhibitory Concentration 50; Iraq; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Salmonella typhi; Tobramycin; Typhoid Fever | 2020 |
Occurrence of Campylobacter spp. in Swedish calves, common sequence types and antibiotic resistance patterns.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Cattle; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones; Sweden; Whole Genome Sequencing | 2021 |
Genomic Background Governs Opposing Responses to Nalidixic Acid upon Megaplasmid Acquisition in
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gene Transfer Techniques; Genome, Bacterial; Nalidixic Acid; Plasmids; Pseudomonas putida | 2021 |
Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues.
Topics: Adenosine Deaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Ciprofloxacin; COVID-19; Creatinine; Fluoroquinolones; Glucose; Glutathione; Glutathione Peroxidase; Levofloxacin; Lipid Peroxidation; Malondialdehyde; Moxifloxacin; Nalidixic Acid; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; SARS-CoV-2; Superoxide Dismutase; Triglycerides | 2022 |
Monitoring antimicrobial resistance trends in Salmonella spp. from poultry in Eastern Spain.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Salmonella; Spain; Sulfamethoxazole; Tetracycline; Turkeys | 2022 |
Patterns of antimicrobial resistance in Salmonella isolates from fattening pigs in Spain.
Topics: Animals; Anti-Bacterial Agents; Bayes Theorem; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Spain; Sulfamethoxazole; Swine | 2022 |
Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Quinolones; Salmonella; Salmonella enterica; Salmonella typhi; Typhoid Fever | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Comparison of disk diffusion and broth microdilution methods for antimicrobial susceptibility testing of Campylobacter isolates of meat origin.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Erythromycin; Gentamicins; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Streptomycin; Tetracycline | 2023 |
Distribution of Virulence Genes in
Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Clavulanic Acid; Erythromycin; Gentamicins; Humans; Iran; Nalidixic Acid; Virulence | 2023 |
Plasmid-mediated quinolone resistance determinants in clinical bacterial pathogens isolated from the Western Region of Ghana: a cross-sectional study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Ghana; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones | 2022 |
Transferable mechanisms of quinolone resistance are more frequent among enterotoxigenic Escherichia coli isolates displaying low-level quinolone resistance.
Topics: Case-Control Studies; Child; Ciprofloxacin; Enterotoxigenic Escherichia coli; Humans; Nalidixic Acid; Quinolones | 2023 |
Antimicrobial resistance of Escherichia coli in the UK: comparison of single vs. pooled samples from healthy pigs.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Swine; United Kingdom | 2023 |